Forbion Capital Partners

Forbion Capital Partners invests in Life Sciences and Biomedical Technology companies developing worldclass drugs and technologies, with a clear focus on product development. .

I work here Suggest edits

forbion.com
Businesses > Venture Capital
B2b
Founded in 2007

More info

Elsewhere

Contributors to this profile

Companies in the same industry

Alexa global traffic share

Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Investments 18

Add info

Add round

01 Aug 2017

$55,000,000

Venture capital (Series C)

Fonds de solidarité FTQ, Domain Associates, BDC Capital, +5

Milestone Pharmaceuticals Closes $55 Million Series C Financing

prnewswire

24 Jul 2017

$30,000,000

Venture capital (Series C)

CD-Venture, Arcus Ventures, NGN Capital, +4

citybizlist : Exosome Diagnostics Raises $30M Series C

citybizlist

07 Feb 2017

€29,000,000

Venture capital (Series B)

Sunstone Capital, Seroba Kernel, Forbion Capital Partners, +2

Prexton Therapeutics, participated by Ysios Capital, Series B financing round raises € 29 millions to advance its novel Parkinson’s therapeutic.es

capital-riesgo

05 Jan 2017

£23,000,000

Venture capital (Series B)

Fountain Healthcare Partners, OrbiMed, Novo A/S, +2

NeRRE Therapeutics picks up Series B funds

PE Hub

06 Sep 2016

€15,000,000

Venture capital (Series A)

Sunstone Capital, MP Healthcare Venture Management, NRW.BANK, +3

Rigontec Raises €15M in Third Closing of Series A Funding

FinSMEs

15 Jun 2016

€22,000,000

Venture capital (Series B)

EMBL Ventures, Forbion Capital Partners, Edmond de Rothschild Investment Partners, +2

Allecra Therapeutics Announces €22 Million Series B Financing

prnewswire

16 Feb 2016

$15,000,000

Venture capital (Series B)

New Science Ventures, Third Point Ventures, Forbion Capital Partners

Akarna Therapeutics Closes $15M Series B Financing

FinSMEs

07 Jan 2016

$60,000,000

Venture capital (Series B)

Tiger Management, Qiagen, Arcus Ventures, +4

Exosome Diagnostics Completes $60 Million Series B Financing

businesswire

02 Sep 2015

$17,600,000

Venture capital (Series B)

Tiger Management, CD-Venture, Arcus Ventures, +2

Exosome Diagnostics Raises $17.6 Million in Second Round Series B Financing

BioPortfolio

11 Mar 2014

$27,000,000

Venture capital (Series B)

b-to-v Partners AG, Qiagen, Arcus Ventures, +2

Exosome Diagnostics raises USD 27m in Series B Financing Partners AG

b-to-v

25 Jul 2012

$60,000,000

Venture capital (Series D)

RA Capital Management, ARCH Venture Partners, Third Rock Ventures, +4

20 Apr 2011

$30,000,000

Venture capital

Easton Capital, ARCH Venture Partners, Third Rock Ventures, +2

04 Feb 2011

$48,268,413

Venture capital (Series B)

Advent Venture Partners, Auriga Partners, Crédit Agricole Private Equity, +5

04 Jan 2011

$33,000,000

Venture capital

Adams Street Partners, Endeavour Vision, Leader Ventures, +5

11 May 2010

$20,000,000

Venture capital (Series A)

NGN Capital, Forbion Capital Partners

12 Mar 2010

$35,000,000

Venture capital (Series B)

Easton Capital, Third Rock Ventures, Forbion Capital Partners, +2

30 Mar 2009

$40,000,000

Venture capital (Series F)

Crédit Agricole Private Equity, Scottish Equity Partners (SEP), New Science Ventures, +4

Index

By TNW